5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).

5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19). [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul 2006 - 3458-64 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2005.04.4685 doi


Antiemetics--administration & dosage
Canada
Dexamethasone--administration & dosage
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Nausea--drug therapy
Ondansetron--administration & dosage
Quality of Life
Radiotherapy--adverse effects
Serotonin 5-HT3 Receptor Antagonists
Serotonin Antagonists--administration & dosage
Treatment Outcome
Vomiting--etiology